Collaboration arrangement between the Department of Health and Aged Care and Health Technology Assessment bodies in the United Kingdom and Canada

5 September 2022 - The Department of Health and Aged Care has signed an international collaboration arrangement with five like minded ...

Read more →

Cost‐effectiveness and financial risks associated with immune checkpoint inhibitor therapy

1 May 2020 - The reimbursement of the immune checkpoint inhibitors is challenging.  ...

Read more →

The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challenges

20 February 2018 - Good practices for budget impact analysis have been increasingly developed since the year 2000.  ...

Read more →

A comparative study of drug listing recommendations and the decision-making process in Australia, the Netherlands, Sweden, and the UK

11 October 2016 - Drug listing recommendations from health technology assessment agencies often fail to coincide with one another.  ...

Read more →